IQGAP3: A Potential Drug Target and Biomarker for Neurological Conditions

Target Name: IQGAP3

NCBI ID: G128239

IQGAP3

Other Name(s): IQGA3_HUMAN | MGC10831 | IQ motif containing GTPase activating protein 3 | MGC10170 | MGC1947 | Ras GTPase-activating-like protein IQGAP3

IQGAP3: A Potential Drug Target and Biomarker for Neurological Conditions

IQGAP3 (IQGA3_HUMAN), also known as human Intelligence Quotient (IQ), is a gene that has been linked to human intelligence. Researchers have been studying the gene for years, and recent studies have shed new light on its role in human intelligence.

IQGAP3 is a gene that encodes a protein known as IQGAP3. This protein is involved in the regulation of neural stem cells, which are important for the development and maintenance of the nervous system. The IQGAP3 gene has also been linked to the development of certain neurological conditions, such as Alzheimer's disease and Parkinson's disease.

Recent studies have shown that IQGAP3 plays a key role in the development and progression of these conditions. Studies have also found that people with certain genetic variations in the IQGAP3 gene are at an increased risk of developing these conditions.

One of the most promising aspects of IQGAP3 is its potential as a drug target. Researchers are studying the IQGAP3 gene to find new ways to treat neurological conditions. They are also exploring the use of IQGAP3 as a biomarker to diagnose and monitor the progression of these conditions.

In addition to its potential as a drug target, IQGAP3 is also an interesting biomarker for certain neurological conditions. Studies have shown that people with certain genetic variations in the IQGAP3 gene may be at an increased risk of developing conditions such as Alzheimer's disease and Parkinson's disease.

Researchers are also studying the IQGAP3 gene to better understand its role in the development and progression of these conditions. They are using a variety of techniques, including genetic engineering and RNA sequencing, to study the gene and its effects on the nervous system.

Overall, IQGAP3 is a gene that has the potential to revolutionize our understanding of human intelligence. By studying the IQGAP3 gene, researchers can gain new insights into the role of this gene in the development and progression of neurological conditions.

IQGAP3 is also a potential drug target for treating these conditions. By developing new treatments based on IQGAP3, researchers can improve treatment outcomes and reduce the burden of these conditions on patients.

As with any new drug or biomarker, further research is needed to fully understand the role of IQGAP3 in human intelligence and its potential as a drug target. Researchers are currently working to refine our understanding of the IQGAP3 gene and its effects on the nervous system.

In conclusion, IQGAP3 is a gene that has the potential to be a drug target and a biomarker for certain neurological conditions. As research continues to advance, we can expect to learn more about the role of this gene in human intelligence and its potential as a treatment for a variety of conditions.

Protein Name: IQ Motif Containing GTPase Activating Protein 3

The "IQGAP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IQGAP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets